Topics

Recordati's Isturisa Approved For Cushing's In EU

05:30 EST 16 Jan 2020 | SCRIP

Acquired from Novartis last year, Isturisa is forecast to have peak sales of over $100m. Now all eyes will be...

      

Related Stories

 

Original Article: Recordati's Isturisa Approved For Cushing's In EU

NEXT ARTICLE

More From BioPortfolio on "Recordati's Isturisa Approved For Cushing's In EU"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...